Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Syros Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Syros Pharmaceuticals Inc. market cap is $2,700.00.
What is the 52-week high for Syros Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Syros Pharmaceuticals Inc. 52 week high is $3.40 as of September 28, 2025.
What is the 52-week low for Syros Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Syros Pharmaceuticals Inc. 52 week low is $0.0001 as of September 28, 2025.
What is Syros Pharmaceuticals Inc. stock price today?
Syros Pharmaceuticals Inc. stock price today is $0.0001.
What was Syros Pharmaceuticals Inc. stock price yesterday?
Syros Pharmaceuticals Inc. stock price yesterday was $0.0001.
What is the PE ratio of Syros Pharmaceuticals Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Syros Pharmaceuticals Inc.’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Syros Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Syros Pharmaceuticals Inc. P/B ratio is -0.0002.
What is the 50-day moving average of Syros Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Syros Pharmaceuticals Inc. 50-day moving average is $0.0038.
